Last reviewed · How we verify

NCT04681560

Impact of Platinum-based Cancer Treatment on Endothelial Function

Completed Last updated 23 December 2020
What this trial tests

trial in High Blood Pressure in 60 participants. Completed in 20 January 2020.

Timeline
18 January 2018
Primary endpoint
9 December 2019
20 January 2020

Quick facts

Lead sponsorI.M. Sechenov First Moscow State Medical University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date18 January 2018
Primary completion9 December 2019
Estimated completion20 January 2020
Sites2 locations across Russia

Conditions studied

Sponsor

I.M. Sechenov First Moscow State Medical University

Who can join

18 and older, any sex, with High Blood Pressure or Cardiovascular Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this research we investigate endothelial function in cancer patients who received platinum based chemotherapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for High Blood Pressure

Currently open trials in the same condition.

Other I.M. Sechenov First Moscow State Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04681560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing